News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Melanoma Diagnostics Leader, Mela Sciences (MELA), Participates in Skin Cancer Diagnostic Workshop with Leading German Dermatologists, Hosted by Germany’s Augsburg Clinic


12/9/2013 7:06:47 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MELA Sciences, Inc. (NASDAQ:MELA), designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage, participated in a two-day hands-on skin cancer diagnostics workshop in Augsburg, Germany, where leading dermatologists examined “high-risk” melanoma patients with MelaFind® and also participated in an imaging devices exhibit.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES